Search research articles
Contact Us
Filters
Showing results (131-140 of 352) with videos related to
Page
of 36
Sort By:
Inflammatory Bowel Diseases
|
June 9, 2009
Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection
Stavroula Koilakou, Johannes Sailer, Philipp Peloschek, et al.
The American Journal of Gastroenterology
|
September 25, 2013
Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation
Sieglinde Angelberger, Walter Reinisch, Athanasios Makristathis, et al.
The American Journal of Gastroenterology
|
January 8, 2026
Clinical Trial Endpoints for Perianal Fistulizing Crohn's Disease
Walter Reinisch, Raja Atreya, Florian Rieder, et al.
Digestive Diseases and Sciences
|
April 29, 2023
Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study
Emily C L Wong, Shahin Merat, Cristina Monaco, et al.
Journal of Crohn'S & Colitis
|
September 20, 2024
Outcomes of Patients With Prior Biologic Intolerance Are Better Than Those With Biologic Failure in Clinical Trials of Inflammatory Bowel Disease
Sunil Samnani, Emily C L Wong, Hasan Hamam, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 10, 2021
Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn's Disease
Neeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Journal of Crohn'S & Colitis
|
February 7, 2019
Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials
Stephen Hanauer, William J Sandborn, Jean-Frederic Colombel, et al.
Scandinavian Journal of Gastroenterology
|
November 4, 2005
A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis
Alexander Teml, Matthias Schwab, Marieluise Harrer, et al.
Journal of Crohn'S & Colitis
|
April 7, 2012
Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trial
Edouard Louis, Robert Löfberg, Walter Reinisch, et al.
Inflammatory Bowel Diseases
|
July 8, 2020
Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease
Walter Reinisch, Krisztina Gecse, Jonas Halfvarson, et al.
Page
of 36
Search research articles
Search
Showing results (131-140 of 352) with videos related to
Sort By:
Page
of 36
Inflammatory Bowel Diseases
|
June 9, 2009
Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection
Stavroula Koilakou, Johannes Sailer, Philipp Peloschek, et al.
The American Journal of Gastroenterology
|
September 25, 2013
Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation
Sieglinde Angelberger, Walter Reinisch, Athanasios Makristathis, et al.
The American Journal of Gastroenterology
|
January 8, 2026
Clinical Trial Endpoints for Perianal Fistulizing Crohn's Disease
Walter Reinisch, Raja Atreya, Florian Rieder, et al.
Digestive Diseases and Sciences
|
April 29, 2023
Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study
Emily C L Wong, Shahin Merat, Cristina Monaco, et al.
Journal of Crohn'S & Colitis
|
September 20, 2024
Outcomes of Patients With Prior Biologic Intolerance Are Better Than Those With Biologic Failure in Clinical Trials of Inflammatory Bowel Disease
Sunil Samnani, Emily C L Wong, Hasan Hamam, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 10, 2021
Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn's Disease
Neeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Journal of Crohn'S & Colitis
|
February 7, 2019
Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials
Stephen Hanauer, William J Sandborn, Jean-Frederic Colombel, et al.
Scandinavian Journal of Gastroenterology
|
November 4, 2005
A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis
Alexander Teml, Matthias Schwab, Marieluise Harrer, et al.
Journal of Crohn'S & Colitis
|
April 7, 2012
Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trial
Edouard Louis, Robert Löfberg, Walter Reinisch, et al.
Inflammatory Bowel Diseases
|
July 8, 2020
Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease
Walter Reinisch, Krisztina Gecse, Jonas Halfvarson, et al.
Page
of 36